424 related articles for article (PubMed ID: 22059355)
1. Immunomodulatory effects of secondary hyperparathyroidism on circulating CD4+ and CD8+ T-lymphocytes in chronic renal failure patients.
El Kelany MA; Maklad SS; El Fouhil DF; El Etreby EA; Saleh LH; El Sheikh NA
Egypt J Immunol; 2009; 16(2):71-82. PubMed ID: 22059355
[TBL] [Abstract][Full Text] [Related]
2. Immunologic disturbances and levels of parathyroid hormone in uremic patients in replacement dialysis therapy.
Angelini D; Carlini A; Mazzotta L; Mei E; Grassi R; Giusti R; Neri M; Fiorini I; Antonelli A
Clin Nephrol; 1994 Oct; 42(4):246-50. PubMed ID: 7834917
[TBL] [Abstract][Full Text] [Related]
3. Naïve and central memory T-cell lymphopenia in end-stage renal disease.
Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Kidney Int; 2006 Jul; 70(2):371-6. PubMed ID: 16738532
[TBL] [Abstract][Full Text] [Related]
4. Cellular immunity and levels of parathyroid hormone in uremic patients receiving hemodialysis.
Griveas I; Visvardis G; Papadopoulou D; Mitsopoulos E; Kyriklidou P; Manou E; Meimaridou D; Ginikopoulou E; Sakellariou G; Fleva A; Zilidou R; Paulitou A
Ren Fail; 2005; 27(3):275-8. PubMed ID: 15957542
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile-secretion of parathyroid hormone in patients with chronic renal failure.
de Francisco AL; Amado JA; Cotorruelo JG; González M; de Castro SS; Canga E; de Bonis E; Ruiz JC; Arias M; Gonzalez-Macías J
Clin Nephrol; 1993 Apr; 39(4):224-8. PubMed ID: 8491053
[TBL] [Abstract][Full Text] [Related]
7. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients.
Chung BH; Kim KW; Sun IO; Choi SR; Park HS; Jeon EJ; Kim BM; Choi BS; Park CW; Kim YS; Cho ML; Yang CW
Immunol Lett; 2012 Jan; 141(2):181-9. PubMed ID: 22004873
[TBL] [Abstract][Full Text] [Related]
8. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor genotype influences parathyroid hormone and calcitriol levels in predialysis patients.
Marco MP; Martínez I; Amoedo ML; Borràs M; Saracho R; Almirall J; Fibla J; Fernández E
Kidney Int; 1999 Oct; 56(4):1349-53. PubMed ID: 10504487
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies.
Borges A; Borges M; Fernandes J; Nascimento H; Sameiro-Faria M; Miranda V; Reis F; Belo L; Costa E; Santos-Silva A
Ren Fail; 2011; 33(2):138-43. PubMed ID: 21332334
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
12. The set point of parathyroid hormone stimulation by calcium is normal in progressive renal failure.
Cardinal H; Brossard JH; Roy L; Lepage R; Rousseau L; D'Amour P
J Clin Endocrinol Metab; 1998 Nov; 83(11):3839-44. PubMed ID: 9814455
[TBL] [Abstract][Full Text] [Related]
13. Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?
Tzanno-Martins C; Futata E; Jorgetti V; Duarte AJ
Clin Nephrol; 2000 Jul; 54(1):22-9. PubMed ID: 10939753
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin C on parathyroid hormone in hemodialysis patients with mild to moderate secondary hyperparathyroidism.
Sanadgol H; Bayani M; Mohammadi M; Bayani B; Mashhadi MA
Iran J Kidney Dis; 2011 Nov; 5(6):410-5. PubMed ID: 22057074
[TBL] [Abstract][Full Text] [Related]
15. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy.
Angelini D; Carlini A; Giusti R; Grassi R; Mei E; Fiorini I; Mazzotta L; Antonelli A
Artif Organs; 1993 Feb; 17(2):73-5. PubMed ID: 8382471
[TBL] [Abstract][Full Text] [Related]
17. T-cell subset counts and serum immunoglobulin concentrations in patients with chronic renal failure at the Kenyatta National Hospital.
Gogo KO; McLigeyo SO; Bwayo JJ; Mumo JM
East Afr Med J; 1998 May; 75(5):271-3. PubMed ID: 9746996
[TBL] [Abstract][Full Text] [Related]
18. Evidence of impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism.
Alexiewicz JM; Gaciong Z; Klinger M; Linker-Israeli M; Pitts TO; Massry SG
Am J Nephrol; 1990; 10(6):495-501. PubMed ID: 2075908
[TBL] [Abstract][Full Text] [Related]
19. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient.
Rodriguez M; Caravaca F; Fernandez E; Borrego MJ; Lorenzo V; Cubero J; Martin-Malo A; Betriu A; Jimenez A; Torres A; Felsenfeld AJ
Kidney Int; 1999 Jul; 56(1):306-17. PubMed ID: 10411707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
